Adalimumab biosimilar in rheumatoid arthritis: a total-evidence assessment to evaluate equivalence with the originator based on network meta-analysis

MeSH terms

• Adalimumab / adverse effects
• Adalimumab / therapeutic use*
• Antirheumatic Agents / adverse effects
• Antirheumatic Agents / therapeutic use*
• Arthritis, Rheumatoid / diagnosis
• Arthritis, Rheumatoid / drug therapy*
• Arthritis, Rheumatoid / immunology
• Biosimilar Pharmaceuticals / adverse effects
• Biosimilar Pharmaceuticals / therapeutic use*
• Drug Therapy, Combination
• Humans
• Methotrexate / therapeutic use
• Therapeutic Equivalency
• Treatment Outcome